(6S,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione, 99%

cas: 171596-28-4 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

(6S,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione, 99% (CAS 171596-28-4) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 100mg, 250mg, 1g. Oferty producentów: BLDpharm, Chemat.

• 2D
• 3D

(2S,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione (CAS 171596-28-4) to związek chemiczny o wzorze sumarycznym C22H19N3O4 i masie molowej 389.4 g/mol. Nazwa systematyczna IUPAC: (2S,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione. InChIKey: WOXKDUGGOYFFRN-IERDGZPVSA-N.

Dane identyfikacyjne

Wzór sumaryczny	C22H19N3O4
Masa molowa	389.4 g/mol
Nazwa IUPAC	(2S,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
InChIKey	WOXKDUGGOYFFRN-IERDGZPVSA-N
SMILES	CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36

Dane obliczone przez PubChem (NCBI)

Synonimy: cis-Tadalafil, Tadalafil, (6S,12AR)-, Tadalafil impurity C [EP], TADALAFIL IMPURITY C [EP IMPURITY], TADALAFIL IMPURITY C (EP IMPURITY), Tadalafil impurity, 6S,12ar diastereomer-(USP), Tadalafil impurity, 6S,12ar diastereomer-[USP], Tadalafil 6S,12ar diastereomer, Tadalafil impurity C, Tadalafil EP Impurity C

Powiązane formy tego związku

(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

(2S,8S)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-(trideuteriomethyl)-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

(2R,8S)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

(2S,8R)-2-(1,3-benzodioxol-5-yl)-6-(trideuteriomethyl)-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

(2R)-2-(1,3-benzodioxol-5-yl)-6-(trideuterio(113C)methyl)-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

Izomery (ten sam wzór sumaryczny)

(2R,5S,8R)-2-(1,3-benzodioxol-5-yl)-5-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione C₂₂H₁₉N₃O₄

5-(isoquinolin-5-yloxymethyl)-N-[(3-methoxyphenyl)methyl]-1,2-oxazole-3-carboxamide C₂₂H₁₉N₃O₄

2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-pyrimidin-2-ylpropanoic acid C₂₂H₁₉N₃O₄

2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-pyrimidin-4-ylpropanoic acid C₂₂H₁₉N₃O₄

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-pyrimidin-2-ylpropanoic acid C₂₂H₁₉N₃O₄